Retractable Technologies (RVP) Cash from Financing Activities (2010 - 2026)
Retractable Technologies' (RVP) quarterly Cash from Financing Activities came in at -$146823.0 in Q1 2026, down 5.23% YoY from -$154924.1 in Q1 2025, and down 1.49% on a QoQ basis from -$144673.0 in Q4 2025.
Retractable Technologies (RVP) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Cash from Financing Activities data on file, last reported at -$146823.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 5.23% year-over-year to -$146823.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$574617.0 (down 5.69% YoY) and the FY2025 annual result came in at -$567321.0, down 5.96% from the prior year.
- Cash from Financing Activities slipped to -$146823.0 in Q1 2026, from -$144673.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $4.7 million in Q3 2022 to a low of -$2.8 million in Q4 2022.
- A 5-year average of $275598.9 and a median of -$134252.0 in 2024 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 95.1% in 2023, down 4922.48% in 2023.
- Tracing RVP's Cash from Financing Activities over 5 years: stood at -$2.8 million in 2022, then jumped by 95.1% to -$136357.0 in 2023, then slipped by 0.47% to -$136996.0 in 2024, then retreated by 5.6% to -$144673.0 in 2025, then declined by 1.49% to -$146823.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$146823.0 (Q1 2026), -$144673.0 (Q4 2025), and -$142396.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Retractable Technologies | 21.67 Mn | -18.20 Mn | 190,852.00 | -198,146.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146,823.00 |
| Mar 31, 2026 | -146,823.00 |
| Dec 31, 2025 | -144,673.00 |
| Dec 31, 2025 | -144,673.00 |
| Sep 30, 2025 | -142,396.00 |
| Sep 30, 2025 | -142,396.00 |
| Jun 30, 2025 | -140,725.00 |
| Jun 30, 2025 | -140,725.00 |
| Mar 31, 2025 | -139,527.00 |
| Mar 31, 2025 | -139,527.00 |
| Dec 31, 2024 | -136,996.00 |
| Dec 31, 2024 | -136,996.00 |
| Sep 30, 2024 | -134,252.00 |
| Sep 30, 2024 | -134,252.00 |
| Jun 30, 2024 | -132,926.00 |
| Jun 30, 2024 | -132,926.00 |
| Mar 31, 2024 | -131,259.00 |
| Mar 31, 2024 | -131,259.00 |
| Dec 31, 2023 | -136,357.00 |
| Dec 31, 2023 | -136,357.00 |